Vaccine Immunity and Inflammation in the Aging Person Living With HIV
Hennepin Healthcare Research Institute · with National Institute on Aging (NIA) · NCT06514547
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 250
- US sites recruiting
- 1
- Study start
- July 8, 2024
- Record last updated
- June 12, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Being studied: Conjugate Pneumococcal Vaccine 20 (PCV20)
Conditions: HIV Infections; Age
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age>=18 years
- HIV Diagnosis
- On Antiretroviral Therapy with HIV Viral Load\<200 within last year
Exclusion Criteria
- Other significant immunosuppressing condition
- Age\< 18 years
- Pregnancy (at enrollment)
- Contraindication to pneumococcal vaccination
- Known contraindication to non-clinical blood draws (severe anemia last hemoglobin \<8g/dl)
- Subjects who, in the opinion of the Investigator, may be non-adherent to study schedules or procedures.
- Adults unable to consent
- Individuals with impaired ability to consent
- Incarceration at time of enrollment
Controls inclusion criteria
- Age>=18 years
- HIV Ag-Ab test negative
Recruiting US locations
Hennepin Healthcare System
Minneapolis, MN 55415
Site contact: Anne Frosch, MD
Study contacts (from the official record)
- Anne Frosch, MD · (612)-283-4349 · Anne.Frosch@hcmed.org
- Marya Abd El Hadi, BSc · (612)-873-6252 · MAbdElHadi@hhrinstitute.org
Similar studies in Minnesota
All vaccine studies in Minnesota →- RecruitingHealthy volunteersPhase 3
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pfizer
- Location
- Minneapolis, MN + 49 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingHealthy volunteersPhase 3
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
GlaxoSmithKline
- Location
- Mankato, MN + 14 other US sites
- Eligibility basics
- Ages 1–1
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Minneapolis, MN + 78 other US sites
- Eligibility basics
- Ages 18–45